Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
02/17/1998 | US5719169 Substituted benzoylguanidines, their use as a medicament or diagnostic, and medicament containing them |
02/17/1998 | US5719164 Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates |
02/17/1998 | US5719163 Arthritis |
02/17/1998 | US5719149 Morpholine derivatives and their use as therapeutic agents |
02/17/1998 | US5719143 Polysubstituted 3-acylamino-5-phenyl-1, 4-benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them |
02/17/1998 | US5719140 2, 3-, 4-, 5-, 6-, 7-, 8-, 9- and /or 10-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
02/17/1998 | US5719136 Combination of progesterone antagonists and antiestrogens with partial agonistic action for hormone substitution therapy for perimenopausal and postmenopausal women |
02/17/1998 | US5719135 Tyrosine kinase inhibitors |
02/17/1998 | US5719129 Sunscreen agents, antiaging agent, free radical scavenger |
02/17/1998 | US5719125 Human chondromodulin-I protein |
02/17/1998 | US5718897 Contacting with purified clostridiopeptidase a collagenase and a growth factor to increase effects of collagenase |
02/17/1998 | CA1339679C Reduced size lhrh analogs |
02/12/1998 | WO1998005792A2 A novel human leptin receptor gene-related protein |
02/12/1998 | WO1998005783A1 A tumor necrosis factor related ligand |
02/12/1998 | WO1998005782A1 Testis-specific insulin homolog polypeptides |
02/12/1998 | WO1998005776A2 Secreted proteins and polynucleotides encoding them |
02/12/1998 | WO1998005761A1 Age-1 polypeptides and related molecules and methods |
02/12/1998 | WO1998005661A1 Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives |
02/12/1998 | WO1998005642A1 Cftr channel activator compounds and pharmaceutical compositions containing same |
02/12/1998 | WO1998005637A1 Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a¿2? |
02/12/1998 | WO1998005635A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
02/12/1998 | WO1998005361A2 Long-acting drugs and pharmaceutical compositions comprising them |
02/12/1998 | WO1998005350A1 Materials and methods for treatment of plaquing diseases |
02/12/1998 | WO1998005349A1 A novel method of detecting and treating cancer |
02/12/1998 | WO1998005347A1 Compounds that inhibit interaction between signal-transducing proteins and the glgf (pdz/dhr) domain and uses thereof |
02/12/1998 | WO1998005343A1 Anti-stress drugs and functional foods having anti-stress effects |
02/12/1998 | WO1998005341A1 The use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus |
02/12/1998 | WO1998005338A2 Use of a dehydroepiandrosterone derivative for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue |
02/12/1998 | WO1998005336A1 Inhibitors of cysteine protease |
02/12/1998 | WO1998005333A1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
02/12/1998 | WO1998005329A1 Il-8 receptor antagonists |
02/12/1998 | WO1998005328A1 Il-8 receptor antagonists |
02/12/1998 | WO1998005317A1 Il-8 receptor antagonists |
02/12/1998 | WO1997044354A3 Synthesis of soluble beta-sheet forming peptides |
02/12/1998 | DE19642872C1 Use of sterol sulphate compounds to inhibit serine protease |
02/12/1998 | CA2263154A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
02/12/1998 | CA2262900A1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
02/12/1998 | CA2262624A1 A novel method of detecting and treating cancer |
02/12/1998 | CA2262399A1 Secreted proteins and polynucleotides encoding them |
02/12/1998 | CA2262223A1 Novel carbocyclic diarylmethylene derivatives, methods for preparing same, and therapeutical uses thereof |
02/12/1998 | CA2261783A1 1,2-diarylindole as cox-2 inhibitors |
02/12/1998 | CA2261742A1 The use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus |
02/12/1998 | CA2261573A1 A novel human leptin receptor gene-related protein |
02/12/1998 | CA2260742A1 Compounds that inhibit interaction between signal-transducing proteins and the glgf (pdz/dhr) domain and uses thereof |
02/12/1998 | CA2233987A1 Materials and methods for treatment of plaquing diseases |
02/11/1998 | EP0823478A2 Human cartilage gp 39-like gene |
02/11/1998 | EP0823437A2 8-Substituted B-nor-6-thiaequilenin compounds having activity as selective estrogen receptor modulators |
02/11/1998 | EP0822986A1 Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds |
02/11/1998 | EP0822983A1 Apopain |
02/11/1998 | EP0822934A1 Antithrombotic amidinotetrahydropyridylalanine derivatives |
02/11/1998 | EP0822932A1 Piperidine derivatives as diuretic |
02/11/1998 | EP0822830A1 Human antibodies derived from immunized xenomice |
02/11/1998 | EP0822826A1 Nitrosylated neuropeptides |
02/11/1998 | EP0822820A1 NOVEL USE OF (S)-ADENOSYL-L-METHIONINE (SAMe) |
02/11/1998 | EP0776323B1 Salts of an anti-migraine indole derivative |
02/11/1998 | CN1173179A Substituted 2 -(phosphinyloxymethyl) -1, 2, 5 -thiadiazolidin -3 -one 1, 1 -dioxides and compositions and method of use thereof |
02/11/1998 | CN1173176A 2 -substituted 1, 2, 5 -thiadiazolidin-3 -one 1, 1-dioxides and compositions and method of use thereof |
02/11/1998 | CN1173175A Substituted 2 -arylcaronyloxymethyl -1, 2, 5 -thiadiazolidin -3 -one 1, 1-dioxide derivatives and compositions and method of use thereof |
02/11/1998 | CN1173174A Substituted oxazolidine calpain and/or cathepsin B inhibitors |
02/11/1998 | CN1173170A Matrix metalloprotease inhibitors |
02/11/1998 | CN1173132A Dihydropyrimidines and uses thereof |
02/11/1998 | CN1173131A 2 -(2, 3, 5, 6 -tetrafluoro -4 -phridyl) -1, 2, 5 -thiadiazolidin -3 -one 1, 1 -dioxides and compositions and method of use thereof |
02/11/1998 | CN1173130A 2 -heterocyclyloxy and thiomethyl -1, 2, 5 -thiadiazolidin -3 -one 1, 1 -dioxides and compositions and method of use thereof |
02/11/1998 | CN1172801A Fluorinated vitamin D3 analogs |
02/11/1998 | CN1172669A Method for extracting and separating flavone and terlactone from ginkgo leaf by supercritical carbon dioxide |
02/11/1998 | CN1172668A Method for removing phenolic acid from ginkgo leaf extract by supercritical carbon dioxide |
02/11/1998 | CN1172665A Chinese medicinal herb preparation for eliminating human body medicine and waste residuum |
02/11/1998 | CN1172649A Hair regrowth liniment and its preparation method |
02/11/1998 | CN1172614A Antioxidant composition and method for production thereof |
02/11/1998 | CN1037347C Method for preparation polytehoxylated vitamin E |
02/10/1998 | US5717102 Psychotherapeutics; headaches |
02/10/1998 | US5717092 Compounds with improved multi-drug resistance activity |
02/10/1998 | US5717083 Phosphoramidate and phosphorothiomidate oligomeric compounds |
02/10/1998 | US5717062 Cyclic analogs of PTH and PTHrP |
02/10/1998 | US5716982 Retinoids and methods of use of same |
02/10/1998 | US5716980 Alcohol or aldehyde derivatives and their use |
02/10/1998 | US5716979 Tachykinin antagonists |
02/10/1998 | US5716973 Anti-viral compounds |
02/10/1998 | US5716970 Diuretic compound |
02/10/1998 | US5716967 Isoxazoline compounds as antiinflammatory agents |
02/10/1998 | US5716966 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists |
02/10/1998 | US5716959 Administering substituted piperazines having hydroxy- or amino-alkyl groups on one nitrogen and carboxylic, phosphoric or sulfonic alkyl groups on the other nitrogen, for treatment of cancer and autoimmune diseases |
02/10/1998 | US5716956 Dihydrophthalazine antagonists of excitatory amino acid receptors |
02/10/1998 | US5716955 Cytokine inhibitor |
02/10/1998 | US5716949 Heterocyclic compounds |
02/10/1998 | US5716945 Antiinflammatory agents; immunostimulation; cell differentiation; antigrowth agents |
02/10/1998 | US5716943 Phosphinic acid derivatives with metallopeptidase inhibitory activity |
02/10/1998 | US5716936 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders |
02/10/1998 | US5716935 Applying polypeptide in carrier to wound to accelerate healing |
02/10/1998 | US5716934 Eck receptor ligands |
02/10/1998 | US5716929 Inhibitors of interleukin-1β converting enzyme |
02/10/1998 | US5716612 Desensitizing the cancer cell drug resistance |
02/10/1998 | CA2079205C Use of hyaluronic acid and forms to prevent arterial restenosis |
02/10/1998 | CA1339661C Cycloalkylamides of (8b)-1alkyl-6 (substituted)ergolines |
02/06/1998 | CA2212204A1 8-substituted b-nor-6-thiaequilenin compounds having activity as selective estrogen receptor modulators |
02/05/1998 | WO1998004734A1 Synthetic protein folding catalysis |
02/05/1998 | WO1998004709A2 Herpes simplex virus icp4 is an inhibitor of apoptosis |
02/05/1998 | WO1998004694A2 Secreted proteins and polynucleotides encoding them |
02/05/1998 | WO1998004691A1 Human proteolipid |
02/05/1998 | WO1998004686A2 Pro-protein converting enzyme |